The company insists there is ample evidence that the marketing of its products is appropriate for the protection of public health.Read More
Tags : R.J. Reynolds Vapor Co.
RJR presented insufficient scientific evidence that the potential benefit to adult smokers outweighs the risks of youth use, according to the agency. Read More
Featured
Intellectual Property
Litigation
News This Week
Reynolds Vapor Denied New Trial in Vuse Case
Judge N. Carlton Tilley Jr. rejects Reynolds’ assertion that the original trial was unfair. Read More
Reynold’s brand pulls ahead as Juul Labs wrestles with regulatory uncertainty. Read More
Confusion around the FDA’s marketing denial order contributed to Juul’s retreat. Read More
The verdict concerns counterclaims in RJR’s ongoing lawsuit over PMI’s IQOS device.Read More
The case is part of multi-front patent dispute involving IQOS and RJR's Vuse.Read More
Featured
Intellectual Property
Litigation
News This Week
Reynolds Settles Vuse Patent Suit Before Trial
The tobacco giant had argued the relevant parts of the patents were invalid.Read More
This marks the first set of ENDS products ever to be authorized through the PMTA pathway. Read More
The dispute focuses on the coupling of the cartridge to the power source. Read More
